Characterisation of Escherichia coli isolates from the blood of haematological adult patients with bacteraemia: translocation from gut to blood requires the cooperation of multiple virulence factors

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 6, 2015, Pages 1135-1143

  Krawczyk, B ^a   Sledzinska A ^b   Szemiako, K ^a   Samet, A ^b   Nowicki, B ^c   Kur, J ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRULENCE FACTOR;

ADOLESCENT; ADULT; AGED; BACTEREMIA; BACTERIAL TRANSLOCATION; BLOOD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GASTROINTESTINAL TRACT; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BACTERIAL TRANSLOCATION; BLOOD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GASTROINTESTINAL TRACT; GENOTYPE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84939951957     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2331-z     Document Type: Article

References (37)

1. Penack O, Rempf P, Eisenblätter M, Stroux A, Wagner J, Thiel E, Blau IW (2007) Bloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood cultures. Ann Oncol 18:1870–1874
2. Rosa RG, Goldani LZ (2014) Aetiology of bacteraemia as a risk factor for septic shock at the onset of febrile neutropaenia in adult cancer patients. Biomed Res Int 2014:561020. doi:10.1155/2014/561020
3. Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, Dupont HL, Adachi JA (2010) Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis 50:374–380. doi:10.1086/649866
4. Buchheidt D, Hummel M, Engelich G, Hehlmann R (2004) Management of infections in critically ill neutropenic cancer patients. J Crit Care 19:165–173
5. Jugo J, Kennedy R, Crowe MJ, Lamrock G, McClurg RB, Rooney PJ, Morris TCM, Johnston PG (2002) Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospital. J Hosp Infect 50:48–55
6. Cometta A, Calandra T, Bille J, Glauser MP (1994) Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N Engl J Med 330:1240–1241
7. Cruciani M, Rampazzo R, Malena M, Lazzarini L, Todeschini G, Messori A, Concia E (1996) Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin Infect Dis 23:795–805
8. Krcmery V, Spanik S, Mrazova M, Trupl J, Grausova S, Grey E, Kukuckova E, Sulcova M, Krupova I, Koren P (2002) Bacteremias caused by Escherichia coli in cancer patients—analysis of 65 episodes. Int J Infect Dis 6:69–73
9. Nørgaard M, Larsson H, Pedersen G, Schønheyder HC, Sørensen HT (2006) Risk of bacteraemia and mortality in patients with haematological malignancies. Clin Microbiol Infect 12:217–223
10. Samet A, Śledzińska A, Krawczyk B, Hellmann A, Nowicki S, Kur J, Nowicki B (2013) Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream. Eur J Clin Microbiol Infect Dis 32:1393–1400
11. Berg RD (1995) Bacterial translocation from the gastrointestinal tract. Trends Microbiol 3:149–154
12. Ostermann H, Kratz-Albers K, Mesters RM, Kiehl M, Kienast J (1997) Reciprocal changes in circulating interleukin-6 and its soluble receptor during evolving sepsis in leukocytopenic patients. J Infect Dis 176:825–828
13. Blijlevens NM, Donnelly JP, De Pauw BE (2000) Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25:1269–1278
14. Hekker TA, Groeneveld AB, Simoons-Smit AM, de Man P, Connell H, MacLaren DM (2000) Role of bacterial virulence factors and host factors in the outcome of Escherichia coli bacteraemia. Eur J Clin Microbiol Infect Dis 19:312–316
15. Kaper JB, Nataro JP, Mobley HLT (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2:123–140
16. Mokady D, Gophna U, Ron EZ (2005) Virulence factors of septicemic Escherichia coli strains. Int J Med Microbiol 295:455–462
17. Johnson JR (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4:80–128
18. Smith JL, Fratamico PM, Gunther NW (2007) Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis 4:134–163
19. Krawczyk B, Samet A, Leibner J, Śledzińska A, Kur J (2006) Evaluation of a PCR melting profile technique for bacterial strain differentiation. J Clin Microbiol 44:2327–2332
20. Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555–4558
21. Adamus-Białek W, Wojtasik A, Majchrzak M, Sosnowski M, Parniewski P (2009) (CGG)4-based PCR as a novel tool for discrimination of uropathogenic Escherichia coli strains: comparison with enterobacterial repetitive intergenic consensus-PCR. J Clin Microbiol 47:3937–3944
22. Johnson JR, Delavari P, Kuskowski M, Stell AL (2001) Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis 183:78–88
23. Johnson JR, Stell AL, Delavari P, Murray AC, Kuskowski M, Gaastra W (2001) Phylogenetic and pathotypic similarities between Escherichia coli isolates from urinary tract infections in dogs and extraintestinal infections in humans. J Infect Dis 183:897–906
24. Johnson JR, Stell AL (2000) Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 18:261–272
25. Johnson JR, Brown JJ, Carlino UB, Russo TA (1998) Colonization with and acquisition of uropathogenic Escherichia coli as revealed by polymerase chain reaction-based detection. J Infect Dis 177:1120–1124
26. Schubert S, Rakin A, Karch H, Carniel E, Heesemann J (1998) Prevalence of the “high-pathogenicity island” of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect Immun 66:480–485
27. Le Bouguenec C, Archambaud M, Labigne A (1992) Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol 30:1189–1193
28. Zhao L, Gao S, Huan H, Xu X, Zhu X, Yang W, Gao Q, Liu X (2009) Comparison of virulence factors and expression of specific genes between uropathogenic Escherichia coli and avian pathogenic E. coli in a murine urinary tract infection model and a chicken challenge model. Microbiology 155:1634–1644
29. Kotlowski R, Bernstein CN, Sepehri S, Krause DO (2007) High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 56:669–675
30. Szemiako K, Krawczyk B, Samet A, Śledzińska A, Nowicki B, Nowicki S, Kur J (2013) A subset of two adherence systems, acute pro-inflammatory pap genes and invasion coding dra, fim, or sfa, increases the risk of Escherichia coli translocation to the bloodstream. Eur J Clin Microbiol Infect Dis 32:1579–1582
31. Brzuszkiewicz E, Brüggemann H, Liesegang H, Emmerth M, Olschläger T, Nagy G, Albermann K, Wagner C, Buchrieser C, Emody L, Gottschalk G, Hacker J, Dobrindt U (2006) How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci U S A 103:12879–12884
32. Ejrnæs K, Stegger M, Reisner A, Ferry S, Monsen T, Holm SE, Lundgren B, Frimodt-Møller N (2011) Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation. Virulence 2:528–537. doi:10.4161/viru.2.6.18189
33. Nowicki B, Sledzinska A, Samet A, Nowicki S (2011) Pathogenesis of gestational urinary tract infection: urinary obstruction versus immune adaptation and microbial virulence. BJOG 118:109–112
34. Goluszko P, Moseley SL, Truong LD, Kaul A, Williford JR, Selvarangan R, Nowicki S, Nowicki B (1997) Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. J Clin Invest 99:1662–1672
35. Lasaro MA, Salinger N, Zhang J, Wang Y, Zhong Z, Goulian M, Zhu J (2009) F1C fimbriae play an important role in biofilm formation and intestinal colonization by the Escherichia coli commensal strain Nissle 1917. Appl Environ Microbiol 75:246–251
36. Steinberg SM (2003) Bacterial translocation: what it is and what it is not. Am J Surg 186:301–305
37. Hart A, Nowicki BJ, Reisner B, Pawelczyk E, Goluszko P, Urvil P, Anderson G, Nowicki S (2001) Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin. J Infect Dis 183:1526–1529